Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
NCT04054310
This study is recruiting at 6 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- NASH - Nonalcoholic Steatohepatitis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Perspectum
- Last updated on ClinicalTrials.gov
- May 19, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Arizona Liver Health · Chandler, AZ
Illinois · 1
- RUSH University Medical Center · Chicago, IL
Indiana · 1
- Indiana University Health · Indianapolis, IN
New York · 1
- Icahn School of Medicine at Mount Sinai · New York, NY
Virginia · 2
- University of Virginia · Charlottesville, VA
- Virginia Common wealth University · Richmond, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.